Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07DBE
|
|||
| Former ID |
DND000019
|
|||
| Drug Name |
Amolimogene
|
|||
| Synonyms |
Bepiplasmid, Biotope-CD, Biotope-diabetes, E-7101, HPV DNA vaccine, Eisai HPV E6 E7 plasmid, ZYC-00101, ZYC-101a, ZYC-101A
Click to Show/Hide
|
|||
| Indication | Dysplasia [ICD-11: LB30-LD2F; ICD-10: C92.A2] | Phase 2/3 | [1] | |
| Company |
Eisai
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00264732) A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.